This episode of Pharma Pulse discusses how the FDA’s new plausible mechanism pathway, WeightWatchers’ plans to offer oral Wegovy, and emerging evidence on berberine are shaping the future of obesity ...
Pfizer enters the lucrative weight-loss drug market with a massive $10 billion Metsera acquisition, targeting a $150-200 ...
This comes during a time when when Eli Lilly and Novo Nordisk have been garnering momentum—last week, the FDA added ...
WeightWatchers plans to offer Novo Nordisk's Wegovy as a pill in the U.S. next year, enhancing their partnership. This move ...
WeightWatchers' CEO said on Wednesday it planned to offer Novo Nordisk's much-anticipated Wegovy in pill form if it is ...
WW International ( WW ), popularly known as Weight Watchers, plans to sell Novo Nordisk's ( NVO) weight loss drug Wegovy in ...
WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback